Tirzepatide
Starting at $778.75
Tirzepatide is a dual GLP-1/GIP medication that acts on appetite and digestion pathways. Under the guidance of a Vytal Genix physician, it may help support medical weight-management when combined with nutrition and lifestyle changes. Your provider reviews your health history and labs to determine whether tirzepatide is appropriate and tailors your dosage and plan to your individual needs.
Your formula is customized to support your individual biochemistry
One-to-one physician guidance
Support for long-term weight-management goals*
*Results vary by individual; no specific amount of weight loss is guaranteed.
Doctor-Guided
Licensed Pharmacies
Ships to you after prescription approval
Want to know more before getting started?
Schedule a free consultation and get all the answers you need.
Select Product Quantity
Doctor-Guided
Licensed Pharmacies
Ships to you after prescription approval
Want to know more before getting started?
Schedule a free consultation and get all the answers you need.
Select Product Quantity
How GLP-1/GIP Medications Work
Balances Blood Sugar
Tirzepatide stimulates insulin release when blood sugar rises, which helps support more stable levels after meals. This may help reduce appetite swings and cravings in some patients.
Slows the Stomach
By slowing how quickly food leaves the stomach, tirzepatide can help you feel fuller for longer and may slow the absorption of sugar into the bloodstream.
Dual Effect on Appetite and Eating Habits
Patients using GLP-1 & GIP therapy under medical supervision may find it easier to follow their body’s natural hunger cues and make more intentional decisions about when and how much they eat, especially when combined with nutrition and activity changes.
VYTAL GENIX
Real Doctors, Personalized Care
Licensed Physicians
Ongoing contact & support
All done from home
Starting from $390 / month
Get Preapproved NowLOSE 20%
OF YOUR BODY WEIGHT
Clinical Insights from GLP-1/GIP Studies
LOSE 20%
OF YOUR BODY WEIGHT
LOSE 20%
OF YOUR BODY WEIGHT*
* no specific results guaranteed
Example of weight-change trends observed over 78 weeks in clinical studies of GLP-1/GIP medications when combined with diet and lifestyle changes.
305
Start
280
6 mo.
245
12 mo.
225
18 mo.
Example of weight-change trends observed over 78 weeks in clinical studies of GLP-1 medications when combined with diet and lifestyle changes.
Chart shown is for educational purposes only and is based on published clinical research trends, not on Vytal Genix program data. Individual results vary, and no specific outcome is guaranteed.
At Vytal Genix, GLP-1/GIP therapy is combined with lifestyle guidance and ongoing medical support to help eligible patients work toward their weight-management goals.
Weight Loss FAQs
At Vytal Genix, we believe in helping you feel your best through personalized, medically supervised weight-management programs.
GLP-1 (glucagon-like peptide-1) medications, such as semaglutide, mimic a natural hormone in your body that helps regulate blood sugar, appetite, and digestion. They can help you feel fuller for longer and may reduce cravings, which can support weight-management efforts when combined with nutrition and lifestyle changes. Individual results vary.
GLP-1 therapy is typically prescribed for adults with a BMI of 27 or higher (with weight-related conditions such as high blood pressure or high cholesterol) or a BMI of 30 or above. A licensed provider will review your health history to determine if GLP-1 medication is right for you.
A licensed provider will review your health history to determine if GLP-1 medication is right for you and whether it is clinically appropriate in your case.
When prescribed and monitored by a qualified provider, GLP-1 medications have an established safety profile for approved indications. Some GLP-1 medications are FDA-approved, while compounded versions may be used when clinically appropriate. Compounded medications are prepared by licensed U.S. pharmacies and are not reviewed or approved by the FDA. As with any medication, potential side effects and risks will be reviewed during your consultation.
Some patients notice changes in appetite and early shifts in weight within the first few weeks. In clinical studies, many participants experienced meaningful weight changes over several months when GLP-1 therapy was combined with diet and lifestyle modifications. However, individual experiences vary, and no specific timeline or amount of weight loss can be guaranteed. Your provider will monitor your progress and adjust your plan as needed.
The most common side effects include mild nausea, bloating, or constipation, especially when first starting treatment. These usually improve as your body adjusts. Your provider may recommend gradual dosage increases to minimize discomfort.
Your provider will also review more serious potential side effects and help you decide if this therapy is appropriate for you.
While GLP-1 treatment can help regulate appetite, combining medication with balanced nutrition and regular physical activity tends to lead to better outcomes. Your provider can help create a custom health program that fits your lifestyle and supports your long-term goals.
Important Notice: Tirzepatide and other GLP-1/GIP therapies are prescription medications. At Vytal Genix, treatment is only prescribed when clinically appropriate after evaluation by a licensed provider. Some prescriptions may be filled using compounded medications prepared by licensed U.S. pharmacies; compounded medications are not reviewed or approved by the FDA. Treatment outcomes, including weight changes, vary by individual and are not guaranteed.
